|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.22 EUR | -1.33% |
|
+2.16% | -13.61% |
| 07:13am | BMW : Jefferies remains Neutral | ZD |
| 06:29am | BMW : JP Morgan maintains a Buy rating | ZD |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.75 | 3.69 | 4.61 | 2.73 | 2.32 | |||||
Return on Total Capital | 4.83 | 4.83 | 6.15 | 3.59 | 2.99 | |||||
Return On Equity % | 18.24 | 22.33 | 13.21 | 8.17 | 7.72 | |||||
Return on Common Equity | 18.31 | 22.22 | 12.78 | 8.01 | 7.76 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 18.44 | 16.19 | 17.99 | 14.74 | 13.79 | |||||
SG&A Margin | 7.07 | 6.37 | 6.09 | 6.76 | 6.52 | |||||
EBITDA Margin % | 15.69 | 13.81 | 15.51 | 11.93 | 11.8 | |||||
EBITA Margin % | 12.21 | 10.89 | 12.75 | 8.95 | 8.44 | |||||
EBIT Margin % | 12.03 | 9.86 | 11.81 | 7.95 | 7.43 | |||||
Income From Continuing Operations Margin % | 11.2 | 13.03 | 7.82 | 5.39 | 5.58 | |||||
Net Income Margin % | 11.13 | 12.58 | 7.26 | 5.12 | 5.47 | |||||
Net Avail. For Common Margin % | 11.13 | 12.58 | 7.26 | 5.12 | 5.47 | |||||
Normalized Net Income Margin | 8.67 | 6.47 | 6.34 | 4.66 | 4.71 | |||||
Levered Free Cash Flow Margin | 6.41 | 9.04 | 5.24 | 2.47 | 1.95 | |||||
Unlevered Free Cash Flow Margin | 6.49 | 9.04 | 5.5 | 2.71 | 2.18 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.5 | 0.6 | 0.62 | 0.55 | 0.5 | |||||
Fixed Assets Turnover | 5.05 | 5.25 | 4.63 | 3.81 | 3.36 | |||||
Receivables Turnover (Average Receivables) | 35.91 | 34.79 | 29.85 | 31.65 | 35.49 | |||||
Inventory Turnover (Average Inventory) | 4.16 | 5.01 | 4.44 | 3.68 | 3.57 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.13 | 1.09 | 1.09 | 1.1 | 1.12 | |||||
Quick Ratio | 0.8 | 0.68 | 0.73 | 0.73 | 0.73 | |||||
Operating Cash Flow to Current Liabilities | 0.21 | 0.28 | 0.2 | 0.09 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 10.16 | 10.49 | 12.23 | 11.56 | 10.28 | |||||
Days Outstanding Inventory (Average Inventory) | 87.84 | 72.92 | 82.3 | 99.36 | 102.38 | |||||
Average Days Payable Outstanding | 51.58 | 46.45 | 51.77 | 59.04 | 60.3 | |||||
Cash Conversion Cycle (Average Days) | 46.43 | 36.96 | 42.76 | 51.89 | 52.36 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 137.71 | 103.19 | 102.25 | 117.11 | 112.83 | |||||
Total Debt / Total Capital | 57.93 | 50.78 | 50.56 | 53.94 | 53.01 | |||||
LT Debt/Equity | 82.98 | 58.57 | 56.91 | 70.28 | 69.62 | |||||
Long-Term Debt / Total Capital | 34.91 | 28.83 | 28.14 | 32.37 | 32.71 | |||||
Total Liabilities / Total Assets | 67.27 | 63.03 | 62.96 | 64.52 | 63.19 | |||||
EBIT / Interest Expense | 95.58 | - | 28.87 | 20.88 | 19.67 | |||||
EBITDA / Interest Expense | 128.15 | - | 39.23 | 32.99 | 33.04 | |||||
(EBITDA - Capex) / Interest Expense | 80.87 | - | 22.12 | 10.47 | 11.29 | |||||
Total Debt / EBITDA | 5.77 | 4.63 | 3.81 | 6.22 | 6.63 | |||||
Net Debt / EBITDA | 5.07 | 3.97 | 3.24 | 5.32 | 5.7 | |||||
Total Debt / (EBITDA - Capex) | 9.14 | 8.33 | 6.75 | 19.61 | 19.42 | |||||
Net Debt / (EBITDA - Capex) | 8.03 | 7.15 | 5.74 | 16.75 | 16.67 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 12.37 | 28.2 | 9.04 | -8.44 | -6.27 | |||||
Gross Profit, 1 Yr. Growth % | 68 | 11.96 | 21.15 | -25 | -12.31 | |||||
EBITDA, 1 Yr. Growth % | 99.24 | 12.17 | 22.46 | -29.61 | -7.3 | |||||
EBITA, 1 Yr. Growth % | 170.58 | 13.47 | 27.67 | -35.71 | -11.66 | |||||
EBIT, 1 Yr. Growth % | 176.64 | 4.24 | 30.6 | -38.35 | -12.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 223.13 | 49.1 | -34.53 | -36.88 | -2.96 | |||||
Net Income, 1 Yr. Growth % | 228 | 44.9 | -37.07 | -35.43 | 0.05 | |||||
Normalized Net Income, 1 Yr. Growth % | 200.82 | -4.37 | 6.81 | -32.66 | -5.32 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 227.59 | 45.5 | -35.27 | -34.26 | 2.31 | |||||
Accounts Receivable, 1 Yr. Growth % | -1.41 | 85.19 | -0.87 | -35.09 | 4.38 | |||||
Inventory, 1 Yr. Growth % | 10.27 | 25.49 | 18.2 | 1.15 | -13.09 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.53 | 43.37 | 9.9 | 12.3 | 0.84 | |||||
Total Assets, 1 Yr. Growth % | 5.94 | 7.58 | 1.61 | 6.71 | -0.66 | |||||
Tangible Book Value, 1 Yr. Growth % | 26.44 | 6.46 | 6.47 | 3.62 | 5.11 | |||||
Common Equity, 1 Yr. Growth % | 22.13 | 17.16 | 2.84 | 3.03 | 3.66 | |||||
Cash From Operations, 1 Yr. Growth % | 20.01 | 47.81 | -25.43 | -56.87 | 8.75 | |||||
Capital Expenditures, 1 Yr. Growth % | 7.63 | 36.73 | 20.23 | 12.17 | -10.18 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 2.8 | 79.19 | -36.82 | -56.76 | -26.31 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 0.26 | 77.04 | -33.74 | -54.81 | -24.62 | |||||
Dividend Per Share, 1 Yr. Growth % | 205.26 | 46.55 | -29.41 | -28.3 | 2.33 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.32 | 20.03 | 18.23 | -0.08 | -7.36 | |||||
Gross Profit, 2 Yr. CAGR % | 10.92 | 37.5 | 16.47 | -4.67 | -18.9 | |||||
EBITDA, 2 Yr. CAGR % | 17.59 | 49.95 | 17.2 | -7.16 | -19.22 | |||||
EBITA, 2 Yr. CAGR % | 23.61 | 75.9 | 20.36 | -9.4 | -24.64 | |||||
EBIT, 2 Yr. CAGR % | 23.72 | 70.49 | 16.68 | -10.27 | -26.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 58.23 | 119.49 | -1.2 | -35.72 | -21.74 | |||||
Net Income, 2 Yr. CAGR % | 58.72 | 118 | -4.51 | -36.26 | -19.62 | |||||
Normalized Net Income, 2 Yr. CAGR % | 36.8 | 69.61 | 1.07 | -15.19 | -20.15 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 59.25 | 118.32 | -2.96 | -34.77 | -17.99 | |||||
Accounts Receivable, 2 Yr. CAGR % | -5.27 | 35.12 | 35.49 | -19.79 | -17.69 | |||||
Inventory, 2 Yr. CAGR % | 1.45 | 17.63 | 21.79 | 9.34 | -6.24 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.82 | 21.24 | 25.52 | 11.09 | 6.41 | |||||
Total Assets, 2 Yr. CAGR % | 0.33 | 6.76 | 4.55 | 4.13 | 2.96 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.57 | 16.02 | 6.46 | 5.03 | 4.37 | |||||
Common Equity, 2 Yr. CAGR % | 11.96 | 19.62 | 9.76 | 2.94 | 3.35 | |||||
Cash From Operations, 2 Yr. CAGR % | 108.39 | 33.24 | 4.99 | -43.29 | -31.51 | |||||
Capital Expenditures, 2 Yr. CAGR % | -2.07 | 21.31 | 28.21 | 16.13 | 0.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -51.45 | 36.35 | 6.4 | -47.73 | -43.55 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -51.38 | 33.84 | 8.31 | -45.28 | -41.63 | |||||
Dividend Per Share, 2 Yr. CAGR % | 52.32 | 111.51 | 1.71 | -28.86 | -14.37 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.72 | 11.02 | 16.25 | 8.58 | -2.19 | |||||
Gross Profit, 3 Yr. CAGR % | 6.66 | 11.46 | 31.82 | 0.58 | -7.29 | |||||
EBITDA, 3 Yr. CAGR % | 12.09 | 15.99 | 40.16 | -1.12 | -7.21 | |||||
EBITA, 3 Yr. CAGR % | 15.17 | 20.44 | 58.08 | -2.34 | -10.16 | |||||
EBIT, 3 Yr. CAGR % | 15.45 | 17.16 | 55.99 | -5.67 | -10.99 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 20.65 | 55.12 | 46.65 | -14.91 | -26.26 | |||||
Net Income, 3 Yr. CAGR % | 21.09 | 53.97 | 44.08 | -16.19 | -25.92 | |||||
Normalized Net Income, 3 Yr. CAGR % | 18.68 | 21.41 | 45.38 | -11.73 | -12.02 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 20.77 | 54.52 | 45.58 | -14.77 | -24.21 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.07 | 18.45 | 21.86 | 6.01 | -12.43 | |||||
Inventory, 3 Yr. CAGR % | 4.41 | 8.9 | 17.82 | 14.48 | 1.29 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.81 | 11.39 | 17.34 | 20.95 | 7.56 | |||||
Total Assets, 3 Yr. CAGR % | 2.8 | 2.69 | 5.01 | 5.27 | 2.51 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.86 | 11.15 | 12.74 | 5.51 | 5.06 | |||||
Common Equity, 3 Yr. CAGR % | 9.1 | 13.67 | 13.74 | 7.47 | 3.18 | |||||
Cash From Operations, 3 Yr. CAGR % | 46.57 | 85.89 | 9.8 | -21.95 | -29.54 | |||||
Capital Expenditures, 3 Yr. CAGR % | -5.23 | 9.45 | 20.95 | 22.63 | 6.6 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 13.17 | -24.74 | 5.51 | -21.19 | -41.39 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 15.16 | -24.97 | 5.88 | -19.06 | -39.11 | |||||
Dividend Per Share, 3 Yr. CAGR % | 18.34 | 50.37 | 46.71 | -9.48 | -19.71 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.39 | 7.73 | 9.93 | 6.44 | 6.16 | |||||
Gross Profit, 5 Yr. CAGR % | 3.5 | 4.44 | 10.6 | 4.7 | 8.54 | |||||
EBITDA, 5 Yr. CAGR % | 6.38 | 8.17 | 14.25 | 6.11 | 12.43 | |||||
EBITA, 5 Yr. CAGR % | 7.61 | 9.41 | 17.4 | 7.48 | 17.54 | |||||
EBIT, 5 Yr. CAGR % | 7.71 | 7.67 | 16.12 | 5.3 | 15.44 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.52 | 16.46 | 11.38 | 9.05 | 14.08 | |||||
Net Income, 5 Yr. CAGR % | 12.53 | 15.87 | 10.11 | 8.2 | 14.08 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.68 | 7.16 | 11.29 | 5.18 | 14.4 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.43 | 15.88 | 10.65 | 9.44 | 15.72 | |||||
Accounts Receivable, 5 Yr. CAGR % | -3.92 | 8.55 | 10.13 | 1.35 | 4.16 | |||||
Inventory, 5 Yr. CAGR % | 5.57 | 8.96 | 11.04 | 9.08 | 7.53 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.48 | 11.66 | 10.05 | 11.27 | 12.84 | |||||
Total Assets, 5 Yr. CAGR % | 4.01 | 4.77 | 3.49 | 3.26 | 4.19 | |||||
Tangible Book Value, 5 Yr. CAGR % | 9.52 | 8.08 | 8.49 | 8.66 | 9.31 | |||||
Common Equity, 5 Yr. CAGR % | 9.56 | 10.13 | 9.36 | 9.25 | 9.46 | |||||
Cash From Operations, 5 Yr. CAGR % | 38.04 | 31.82 | 28.27 | 15.62 | -9.09 | |||||
Capital Expenditures, 5 Yr. CAGR % | 2.6 | 4.94 | 6.95 | 12.08 | 12.26 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 2.88 | -10.47 | 10.62 | -34.95 | -17.84 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 2.34 | -10.31 | 12.58 | -33.87 | -16.56 | |||||
Dividend Per Share, 5 Yr. CAGR % | 10.63 | 16.27 | 11.38 | 11.47 | 18.29 |
- Stock Market
- Equities
- BMW Stock
- Financials BMW AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















